CA2336534A1 - Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci - Google Patents

Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci Download PDF

Info

Publication number
CA2336534A1
CA2336534A1 CA002336534A CA2336534A CA2336534A1 CA 2336534 A1 CA2336534 A1 CA 2336534A1 CA 002336534 A CA002336534 A CA 002336534A CA 2336534 A CA2336534 A CA 2336534A CA 2336534 A1 CA2336534 A1 CA 2336534A1
Authority
CA
Canada
Prior art keywords
polypeptide
polynucleotide
antibody
chlamydia
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002336534A
Other languages
English (en)
Inventor
Pamela L. Dunn
Andrew D. Murdin
Raymond P. Oomen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2336534A1 publication Critical patent/CA2336534A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)

Abstract

L'invention concerne un procédé d'immunisation d'un hôte, y compris d'êtres humains, à l'aide d'acides nucléiques, notamment d'ADN, contre des maladies provoquées par une infection par une souche de Chlamydia, spécifiquement C. pneumoniae, au moyen d'un vecteur contenant une séquence nucléotidique codant pour une protéine omp d'une souche de Chlamydia pneumoniae, et un promoteur permettant l'expression du gène omp chez l'hôte. Des modifications sont possibles dans le champ d'application de cette invention.
CA002336534A 1998-07-27 1999-07-27 Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci Abandoned CA2336534A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US9420398P 1998-07-27 1998-07-27
US60/094,203 1998-07-27
US12204599P 1999-03-01 1999-03-01
US60/122,045 1999-03-01
US36043499A 1999-07-26 1999-07-26
US09/360,434 1999-07-26
PCT/IB1999/001333 WO2000006743A2 (fr) 1998-07-27 1999-07-27 Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci

Publications (1)

Publication Number Publication Date
CA2336534A1 true CA2336534A1 (fr) 2000-02-10

Family

ID=27377706

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002336534A Abandoned CA2336534A1 (fr) 1998-07-27 1999-07-27 Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci

Country Status (6)

Country Link
EP (1) EP1108033A2 (fr)
JP (1) JP2002524035A (fr)
AU (1) AU4793499A (fr)
CA (1) CA2336534A1 (fr)
MX (1) MXPA01001090A (fr)
WO (1) WO2000006743A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512730A (en) * 1998-12-04 2003-12-19 Univ Manitoba A immunization procedure against chlamydia infection using an attenuated bacteria comprsing a plasmid with a major outer membrane protein (MOMP) from chlamydial
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726775A4 (fr) * 1993-11-03 1999-03-31 Pfizer Vaccin et procede de traitement contre les infections a chlamydia
EP0915978B1 (fr) * 1996-07-12 2005-12-14 University of Manitoba Vaccination a l'adn contre l'infection due a chlamydia
NZ334568A (en) * 1996-10-28 2000-04-28 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
AU762606B2 (en) * 1997-11-21 2003-06-26 Genset S.A. Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection

Also Published As

Publication number Publication date
WO2000006743A2 (fr) 2000-02-10
MXPA01001090A (es) 2002-06-04
JP2002524035A (ja) 2002-08-06
WO2000006743A3 (fr) 2000-05-04
EP1108033A2 (fr) 2001-06-20
AU4793499A (en) 2000-02-21

Similar Documents

Publication Publication Date Title
AU770905B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US6649370B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU753984B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US6403102B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2336532A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
AU770919B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU5297399A (en) (chlamydia) antigens and corresponding dna fragments and uses thereof
EP1100918A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
CA2336534A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
CA2337493A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants, et utilisations de ceux-ci
AU4793299A (en) (chlamydia) antigens and corresponding dna fragments and uses thereof
AU4792999A (en) (chlamydia) antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
FZDE Dead